The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Ultiva     methyl1-(2- methoxycarbonylethyl)-4...

Synonyms: SureCN41242, CHEMBL1201120, CHEBI:32091, GI-87084B, LS-172838, ...
This record was replaced with 60815.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of REMIFENTANIL

  • BACKGROUND: Clinical studies suggest that intraoperative administration of the clinical remifentanil formulation Ultiva (GlaxoWellcome GmbH & Co, Bad Oldesloe, Germany) increases postoperative pain and postoperative analgesic requirements, but mechanisms remain unclear [1].

High impact information on REMIFENTANIL


Biological context of REMIFENTANIL


Associations of REMIFENTANIL with other chemical compounds


  1. Remifentanil directly activates human N-methyl-D-aspartate receptors expressed in Xenopus laevis oocytes. Hahnenkamp, K., Nollet, J., Van Aken, H.K., Buerkle, H., Halene, T., Schauerte, S., Hahnenkamp, A., Hollmann, M.W., Strümper, D., Durieux, M.E., Hoenemann, C.W. Anesthesiology (2004) [Pubmed]
  2. Effects of remifentanil on N-methyl-D-aspartate receptor: an electrophysiologic study in rat spinal cord. Guntz, E., Dumont, H., Roussel, C., Gall, D., Dufrasne, F., Cuvelier, L., Blum, D., Schiffmann, S.N., Sosnowski, M. Anesthesiology (2005) [Pubmed]
  3. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. James, M.K., Vuong, A., Grizzle, M.K., Schuster, S.V., Shaffer, J.E. J. Pharmacol. Exp. Ther. (1992) [Pubmed]
  4. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. James, M.K., Feldman, P.L., Schuster, S.V., Bilotta, J.M., Brackeen, M.F., Leighton, H.J. J. Pharmacol. Exp. Ther. (1991) [Pubmed]
  5. Remifentanil in obstetric analgesia: a dose-finding study. Volmanen, P., Akural, E.I., Raudaskoski, T., Alahuhta, S. Anesth. Analg. (2002) [Pubmed]
  6. Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat. Haidar, S.H., Moreton, J.E., Liang, Z., Hoke, J.F., Muir, K.T., Eddington, N.D. Journal of pharmaceutical sciences. (1997) [Pubmed]
  7. The effects of transcranial electrical stimulation on opiate-induced analgesia in rats. Kabalak, A.A., Senel, O.O., Gogus, N. Pain research & management : the journal of the Canadian Pain Society = journal de la société canadienne pour le traitement de la douleur. (2004) [Pubmed]
  8. Investigation of the mutation points and effects of some drugs on glucose-6-phosphate dehydrogenase-deficient people in the Erzurum region. Ozmen, I., Ciftçi, M., Küfrevioğlu, O.I., Cüruk, M.A. Journal of enzyme inhibition and medicinal chemistry. (2004) [Pubmed]
WikiGenes - Universities